Publication | Open Access

Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine

Tumor ImmunologyPancreatic CancerMedicineImmunologyTherapeutic VaccinePancreatic SurgeryResected Pancreatic AdenocarcinomaImmunotherapyOncologyRadiation OncologyPoor SurvivalTumor Microenvironment